Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aslan Pharmaceuticals Ltd ADR (ASLN)
NASDAQ:ASLN
Aslan Pharmaceuticals (ASLN) Financial Statements
405 Followers
Aslan Pharmaceuticals Financial Overview
| Dec 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | $ 0.00 |
| EBIT | - | - | $ -9.97M | $ -12.16M | $ -11.85M |
| EBITDA | - | - | $ -9.97M | $ -12.16M | $ -11.85M |
| Net Income Common Stockholders | - | - | $ -10.93M | $ -13.03M | $ -12.94M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 21.25M | $ 8.59K | $ 68.95M | $ 78.12M | $ 87.40M |
| Total Assets | $ 24.63M | $ 61.19M | $ 72.61M | $ 80.61M | $ 90.88M |
| Total Debt | $ 26.83M | $ 29.87M | $ 36.64M | $ 36.47M | $ 36.54M |
| Net Debt | $ 5.57M | $ 29.86M | $ -32.31M | $ -41.65M | $ -50.86M |
| Total Liabilities | $ 37.91M | $ 52.82M | $ 50.55M | $ 47.95M | $ 45.80M |
| Stockholders Equity | $ -13.29M | $ 8.37M | $ 22.06M | $ 32.67M | $ 45.07M |
| Cash Flow | - | ||||
| Free Cash Flow | - | - | - | - | - |
| Operating Cash Flow | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - |
Aslan Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.